The framework for risk-benefit evaluations used in research can shed light on ways of balancing potential social benefits and individual risks that are missing from existing ethical frameworks for public health.
Bruce Philip Blackshaw and Daniel Rodger defend conscientious objection to abortion provision, claiming that the usual arguments critics make to disqualify conscientious objection in health care do not apply in cases of abortion.
To remove the financial barriers associated with oocyte donation, the European Union (EU) allows for donors to be reasonably compensated. This must follow the EU tissue and cell directive that states donation must not result in a donor profiting from compensation for tissue donation.
The relatively recent submissions by state policymakers requesting to close their Medicaid formularies highlighted ethical concerns regarding access and treatment of patients who are poor or vulnerable.
Although payment for enrolling in medical research is not likely to make participation involuntary or invalid, it may create a situation that is not in the best interests of the participant.
The relatively recent submissions by state policymakers requesting to close their Medicaid formularies highlighted ethical concerns regarding access and treatment of patients who are poor or vulnerable.
As opioid overprescribing is a key contributor to the current opioid crisis, implementing appropriate prescribing strategies in medical education may prepare future physicians to appropriately and ethically prescribe opioids.
The American College of Physicians endorses the necessity of a comprehensive process for disclosure of potential conflicts of interest to ensure the integrity of clinical guidelines and guidance statements.
A growing number of physicians and ethicists suggest that religion and prayer do not necessarily fall outside the bailiwick of modern-day Western medicine.
The author investigates the use of a regional state unrepresented patient advocacy committee as an alternative to appointing legal guardians or using physicians as decision makers.
Investigators evaluate medical decision making for patients who are incarcerated and unrepresented and identifies advantages and disadvantages of different classes of decision makers for them.
In cases in which an error is made in the care of an unrepresented patient, the absence of a surrogate does not preclude the clinician’s ethical responsibilities to document, disclose, and, insofar as possible, rectify the mistake.
State medical boards should consider investigating licensees suspected of violating professional standards when providing unproven stem cell interventions, especially those advertising treatment outside their scope of training.
